The Control of Glomerular hemodynamics and its significance in renal dysfunction and hypertension
The Control of Glomerular hemodynamics and its significance in renal dysfunction and hypertension
批准号:
10470215
负责人:
ITO Sadayoshi
金额:
$8.19万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Using isolated microperfused glomerular afferent arterioles, we investigated the mechanism that controls glomerular hemodynamics and their significance in progressive renal dysfunction and hypertension. We first examined interactions among angiotensin type 1 and type 2 (ATィイD21ィエD2 and ATィイD22ィエD2) receptors, nitric oxide (NO), 20-HETE and EET, major metabolites of arachidonic acid via cytochrome P450 pathways in rabbit afferent arterioles. We found that 1) both NO and EET are vasodilators which atlenuate ATィイD21ィエD2 receptor-mediated vasoconstriction, 2) activation of ATィイD22ィエD2 receptor causes vasodilation, 3) the mechanism of ATィイD22ィエD2 receptor-mediated vasodilation involves EET, but no NO, 4) 20-HETE is important for Ang II-induced vasoconstriction.We then examined the role of ATィイD22ィエD2 in the vascular reactivity of the afferent arteriole obtained from prehypertensive young (4 weeks old) spontaneously hypertensive rat (SHR) and the normotensive Wistar-Kyoto rats (WKY). Ang II-induced vasoconstriction was stronger in SHR than WKY afferent arterioles. ATィイD22ィエD2 receptor antagonism augmented Ang II-induced vasoconstriction only WKY afferent arterioles, resulting in no difference in Ang II action between the two. In the presence of an ATィイD21ィエD2 receptor antagonist, Ang II caused vasodilation in preconstricted afferent arteriole of WKY. This dilation was blocked by pretreatment with an ATィイD22ィエD2 receptor antagonist. On the other hand, such dilation was not observed in Ang II-induced afferent arteriolar constriction is exaggerated due, at least in part, to impained function of the ATィイD22ィエD2 receptor-mediated vasoditor mechanism.
期刊论文(54)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Soma J, Sato H, Ito S, Saito T, et al.: "Nephrotic syndrome associated with hypocomplementaemic urticarial vasculitis syndrome : successful treatment with cyclosporin A."Nephrol. Dial. Transplant.. vol.14. 1753-1757 (1999)
Soma J、Sato H、Ito S、Saito T 等人:“与低补体血症性荨麻疹性血管炎综合征相关的肾病综合征:环孢菌素 A 的成功治疗。”Nephrol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takahashi N,Takeuchi K,Ito S.,et al.: "Structure and transcriptional function of the 5'-flanking region of rat thromboxane receptor gene." Biochem.Biophys.Res.Commun.244. 489-493 (1998)
Takahashi N,Takeuchi K,Ito S.,et al.:“大鼠血栓素受体基因 5-侧翼区域的结构和转录功能。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sugawara A.,Hanew K.,Ogawa M.,Ito S.et al.: "A case of inherited GH deficiency with a 6.7-kb deletion of GH-1 gene"Clin. Pediatr. Endocrinol.. 7. 41-46 (1998)
Sukawara A.、Hanew K.、Okawa M.、Ito S.et al.:“遗传性 GH 缺乏症伴 GH-1 基因 6.7-kb 缺失的病例”Clin。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Soma J.,Sato H.,Ito S.,Saito T.: "Nephrotic syndrome associated with hypocomplmentaemic urticarial vasculitis syndrome : successful treatment with cyclosporin A"Nephrol. Dial. Transplant.. 14. 1753-1757 (1999)
Soma J.、Sato H.、Ito S.、Saito T.:“与低补体血症性荨麻疹性血管炎综合征相关的肾病综合征:环孢菌素 A 的成功治疗”Nephrol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishidoya S.,Fukuzaki A.,Kaneto H.,Ito S.et al.: "Chronic unilateral obstruction represented as renin-dependent hypertension"Nephron.. (in press).
Ishidoya S.、Fukuzaki A.、Kaneto H.、Ito S.等人:“慢性单侧梗阻表现为肾素依赖性高血压”肾单位..(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 50 条
Exploration of specific biomarkers for carbonyl stress inducible disease.
-
批准号:24390211
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.65万
-
财政年份:2012
-
负责人:ITO Sadayoshi
-
依托单位:
Role of amine-carbonyl reaction as a novel mechanism for renal disease
-
批准号:22659164
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.07万
-
财政年份:2010
-
负责人:ITO Sadayoshi
-
依托单位:
Mechanisms of cardiovascular-renal connection on life-style diseases
-
批准号:21390259
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.48万
-
财政年份:2009
-
负责人:ITO Sadayoshi
-
依托单位:
Empire, Nation-state and Region in Modern Western World.
-
批准号:15320103
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.18万
-
财政年份:2003
-
负责人:ITO Sadayoshi
-
依托单位:
Cardiorenal association
-
批准号:15390264
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.54万
-
财政年份:2003
-
负责人:ITO Sadayoshi
-
依托单位:
Mechanisms regulating glomerular hemodynamics
-
批准号:12470208
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.96万
-
财政年份:2000
-
负责人:ITO Sadayoshi
-
依托单位:
Control of glomerular function by juxtaglomerular apparatus
-
批准号:08044233
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$1.54万
-
财政年份:1996
-
负责人:ITO Sadayoshi
-
依托单位:
Role of the juxtaglomerular apparatus in hypertension and progressive renal impairment
-
批准号:08457283
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.38万
-
财政年份:1996
-
负责人:ITO Sadayoshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
-
批准号:82372202
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯旭敏
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
多囊卵巢综合征中甲酰肽受体2调控小胶质细胞代谢重编程导致GnRH神经元过度激活及HPO轴异常的病理机制研究
-
批准号:82370797
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陶弢
-
依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
-
批准号:82370865
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄哲
-
依托单位:
骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
-
批准号:82370820
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王天歌
-
依托单位:
Succinate-Succinate Receptor介导的代谢反应在正畸牙根吸收中的作用
-
批准号:82371007
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:雷浪
-
依托单位:
Leptin receptor阳性细胞通过分泌Hedgehog蛋白调控椎间盘退变及修复的谱系研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:傅强
-
依托单位:
拟南芥中水杨酸介导花粉管生长的受体筛选及其分子机理研究
-
批准号:32100576
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:荣朵艳
-
依托单位:
Nek9磷酸化MCL-1调控线粒体自噬和分裂的机制与功能研究
-
批准号:32100598
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:岑旭峰
-
依托单位:
褪黑素促进MCL-1抑制剂诱导白血病细胞凋亡的分子机制研究
-
批准号:32100607
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:叶开琴
-
依托单位: